Clinical Trials
Tallac Reveal They Have Served Their First TAC-001 Patient
In a phase 1/2 clinical trial for patients with locally advanced or metastatic solid tumours, Tallac Therapeutics has reported that the first patient has...
Drug Research
September May Bring Updated COVID-19 Booster Shots To Market
According to the US Department of Health and Human Services, booster shots from Moderna and Pfizer that have been upgraded to target Omicron coronavirus...
Drug Research
Zoryve Cream By Arcutis Receives FDA Approval For Psoriasis
Pfizer previously held out hope that Eucrisa would become the trendiest topical treatment for inflammatory skin conditions. However, the ointment never took off because...
Press Releases
Powerful Pumas Software for Drug Development Modeling and Simulation is Now Available for Desktop Download
Pumas-AI, a science-first organization that turns data into life-saving decisions faster, announced that its Pumas software is now available for desktop download. Pumas is...
Press Releases
GreenLight Biosciences and Samsung Biologics complete first commercial-scale engineering run for mRNA Covid-19 vaccine
GreenLight Biosciences, a biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible for human health and agriculture, and Samsung Biologics, a...
Drug Research
Issues With Accelerated Approval Remain A Problem For FDA
The use of excessively fragile efficacy data and delays in sponsors' presenting living proof from post-approval trials, as well as the approval of some...
Drug Research
The Ratio of NA To NAM As A Test For Cell Therapy Sterility
According to research, the ratio of nicotinic acid (NA) to nicotinamide (NAM) considerably rises when living microorganisms are present inside 24 hours. This ratio...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read